SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about earnings call transcript

05 Feb 2026 Evaluate
Ajanta Pharma has informed that it enclosed transcript of the earnings call held on 30th January 2026 at 04.30 pm has been uploaded on the Company’s website and can be accessed through the link https://ajantapharma.com//images/Earnings-Call-Transcript-Q3-(Oct-Dec)-2025-26.pdf.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2895.85 92.35 (3.29%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×